Nature Communications (Jun 2021)

SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals

  • Nils C. Gassen,
  • Jan Papies,
  • Thomas Bajaj,
  • Jackson Emanuel,
  • Frederik Dethloff,
  • Robert Lorenz Chua,
  • Jakob Trimpert,
  • Nicolas Heinemann,
  • Christine Niemeyer,
  • Friderike Weege,
  • Katja Hönzke,
  • Tom Aschman,
  • Daniel E. Heinz,
  • Katja Weckmann,
  • Tim Ebert,
  • Andreas Zellner,
  • Martina Lennarz,
  • Emanuel Wyler,
  • Simon Schroeder,
  • Anja Richter,
  • Daniela Niemeyer,
  • Karen Hoffmann,
  • Thomas F. Meyer,
  • Frank L. Heppner,
  • Victor M. Corman,
  • Markus Landthaler,
  • Andreas C. Hocke,
  • Markus Morkel,
  • Nikolaus Osterrieder,
  • Christian Conrad,
  • Roland Eils,
  • Helena Radbruch,
  • Patrick Giavalisco,
  • Christian Drosten,
  • Marcel A. Müller

DOI
https://doi.org/10.1038/s41467-021-24007-w
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 15

Abstract

Read online

Viruses manipulate host cell pathways to support infection. Here the authors show that SARS-CoV-2 infection modulates cellular metabolism and limits autophagy, and identify druggable host pathways for virus inhibition.